コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 her before or after infection with Theiler's murine encephalomyelitis virus.
2 seizures induced by pilocarpine or Theiler's murine encephalomyelitis virus.
3 dominant epitope (VP2(121-130)) of Theiler's murine encephalomyelitis virus.
4 sequences with a high homology to Theiler's murine encephalomyelitis virus.
7 (TLR9), and infection with viable Theiler's murine encephalomyelitis virus, activated the cells to u
9 Nippostrongylus brasiliensis, and Theiler's murine encephalomyelitis virus, and they made overtly no
12 mice with Daniel's (DA) strains of Theiler's murine encephalomyelitis virus (DAV) results in virus pe
13 L/6 mice acutely infected with the Theiler's murine encephalomyelitis virus, hippocampal CA1 neurons
14 localization identified persistent Theiler's murine encephalomyelitis virus in oligodendrocytes and a
15 , was tested in the acute phase of Theiler's murine encephalomyelitis virus-induced demyelinating dis
18 immune encephalomyelitis (EAE) and Theiler's murine encephalomyelitis virus-induced demyelinating dis
19 lfate proteoglycan accumulation in Theiler's murine encephalomyelitis virus-induced demyelinating dis
20 e model of multiple sclerosis, the Theiler's murine encephalomyelitis virus-induced demyelinating dis
21 lerosis, relapsing EAE (R-EAE) and Theiler's murine encephalomyelitis virus-induced demyelinating dis
22 ent CD154 blockade at the onset of Theiler's murine encephalomyelitis virus-induced demyelinating dis
25 tal allergic encephalomyelitis and Theiler's murine encephalomyelitis virus-induced demyelination, de
26 e development of acute seizures in Theiler's murine encephalomyelitis virus-induced encephalitis.
29 ld-type Daniel's (wt-DA) strain of Theiler's murine encephalomyelitis virus induces a persistent cent
32 rus-specific T cells in the CNS of Theiler's murine encephalomyelitis virus-infected mice during the
35 30) epitope expressed during acute Theiler's murine encephalomyelitis virus infection, i.v. injection
38 -2b backgrounds were infected with Theiler's murine encephalomyelitis virus intracerebrally and exami
39 sts a diverse group of novel human Theiler's murine encephalomyelitis virus-like cardioviruses that h
42 064) mediates remyelination in the Theiler's murine encephalomyelitis virus mouse model of multiple s
44 ct role for sialic acid binding in Theiler's murine encephalomyelitis virus persistence and chronic d
45 picornavirus, the GDVII strain of Theiler's murine encephalomyelitis virus, requires polypyrimidine
46 infection of susceptible mice with Theiler's murine encephalomyelitis virus results in immune-mediate
47 Infection of susceptible mice with Theiler's murine encephalomyelitis virus results in neurological d
48 ected with a neurotropic strain of Theiler's murine encephalomyelitis virus secreted innate immune cy
49 to the lack of an early functional Theiler's murine encephalomyelitis virus-specific CTL response.
50 e mice with the low-neurovirulence Theiler's murine encephalomyelitis virus strain BeAn results in an
51 meability using a variation of the Theiler's murine encephalomyelitis virus system traditionally used
52 nse against the Daniel's strain of Theiler's murine encephalomyelitis virus (TMEV) 7 days after infec
54 s in the CNS of mice infected with Theiler's murine encephalomyelitis virus (TMEV) and in mice with e
55 imal models of multiple sclerosis: Theiler's murine encephalomyelitis virus (TMEV) and myelin oligode
56 s been of interest with respect to Theiler's murine encephalomyelitis virus (TMEV) because the GDVII
62 and intracerebrally infected with Theiler's murine encephalomyelitis virus (TMEV) cleared virus infe
63 ase following inoculation with the Theiler's murine encephalomyelitis virus (TMEV) compared to infect
64 lergic encephalomyelitis (EAE) and Theiler's murine encephalomyelitis virus (TMEV) disease are two de
65 ce with a nonpathogenic variant of Theiler's murine encephalomyelitis virus (TMEV) engineered to expr
67 of mice persistently infected with Theiler's murine encephalomyelitis virus (TMEV) for evidence that
68 ica (serovar Typhimurium C5TS) and Theiler's murine encephalomyelitis virus (TMEV) in MHC-congenic mo
72 ther members of the TO subgroup of Theiler's murine encephalomyelitis virus (TMEV) induce a persisten
73 ther members of the TO subgroup of Theiler's murine encephalomyelitis virus (TMEV) induce an early tr
74 central nervous system (CNS) with Theiler's murine encephalomyelitis virus (TMEV) induces an immune-
80 of dendritic and glial cells with Theiler's murine encephalomyelitis virus (TMEV) induces various cy
82 ssed cytokine gene activation upon Theiler's murine encephalomyelitis virus (TMEV) infection and pote
88 e model of brain atrophy using the Theiler's murine encephalomyelitis virus (TMEV) infection model of
94 le nitric oxide synthase (iNOS) in Theiler's murine encephalomyelitis virus (TMEV) infection of susce
105 ral injection of C57BL/6 mice with Theiler's murine encephalomyelitis virus (TMEV) is a model of vira
109 with the neurotropic picornavirus Theiler's murine encephalomyelitis virus (TMEV) leads to a progres
110 the present study, we utilized the Theiler's murine encephalomyelitis virus (TMEV) model of MS to exa
111 eficits after demyelination in the Theiler's murine encephalomyelitis virus (TMEV) model of multiple
113 s at sites of demyelination in the Theiler's murine encephalomyelitis virus (TMEV) model of multiple
117 ther members of the TO subgroup of Theiler's murine encephalomyelitis virus (TMEV) produce a chronic
118 te with the Daniels (DA) strain of Theiler's murine encephalomyelitis virus (TMEV) resulted in acute
119 SJL/J mice with the BeAn strain of Theiler's murine encephalomyelitis virus (TMEV) results in a persi
121 f susceptible strains of mice with Theiler's murine encephalomyelitis virus (TMEV) results in immune-
122 polypeptide of the GDVII strain of Theiler's murine encephalomyelitis virus (TMEV) results in the pro
125 lete nucleotide sequences of three Theiler's murine encephalomyelitis virus (TMEV) strains (TO Yale,
126 led that this virus belongs to the Theiler's murine encephalomyelitis virus (TMEV) subgroup of cardio
128 t contiguous coding regions of the Theiler's murine encephalomyelitis virus (TMEV) under the control
129 of mice persistently infected with Theiler's murine encephalomyelitis virus (TMEV) undergo apoptosis,
132 were inoculated intravenously with Theiler's murine encephalomyelitis virus (TMEV), a murine enterovi
135 ilized intracranial infection with Theiler's murine encephalomyelitis virus (TMEV), a picornavirus th
136 infection with the BeAn strain of Theiler's murine encephalomyelitis virus (TMEV), certain mouse str
137 Many viral infections, including Theiler's murine encephalomyelitis virus (TMEV), result in the vig
138 th BeAn, a less virulent strain of Theiler's murine encephalomyelitis virus (TMEV), results in immune
139 owing intracerebral infection with Theiler's murine encephalomyelitis virus (TMEV), susceptible strai
140 after intracerebral infection with Theiler's murine encephalomyelitis virus (TMEV), the levels of mRN
141 ephalomyocarditis virus (EMCV) and Theiler's murine encephalomyelitis virus (TMEV), which are closely
142 pe are resistant to infection with Theiler's murine encephalomyelitis virus (TMEV), which causes chro
143 c cytotoxic T lymphocytes (CTL) in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinat
149 mouse model of multiple sclerosis, Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinat
151 ment of behavioral seizures in the Theiler's murine encephalomyelitis virus (TMEV)-induced seizure mo
152 ss I molecules to brain atrophy in Theiler's murine encephalomyelitis virus (TMEV)-infected transgeni
166 aturally occurring, low pathogenic Theiler's murine encephalomyelitis virus variant showed a single a
167 micry, a nonpathogenic neurotropic Theiler's murine encephalomyelitis virus variant was engineered to
168 for viral myocarditis induced with Theiler's murine encephalomyelitis virus, we conducted multivariat
169 fected with the Daniel's strain of Theiler's murine encephalomyelitis virus were treated with the FDA